Digestive health

What Cologuard Costs and Who Pays for It

Save

Cologuard's insurance story has two parts, and most explanations only cover the easy one. The kit itself is free for most people who qualify under the ACA's screening rule — but what happens to the bill if the test comes back positive is where the real questions start, and where a little advance knowledge saves a surprise call to your insurer.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Does Insurance Cover Cologuard?

Yes, generally — the ACA requires private insurers and Medicare to cover USPSTF-recommended colorectal cancer screening, including Cologuard, with no patient cost-sharing for adults at average risk 1. That's the same no-cost rule that applies to a screening colonoscopy, and it exists because Cologuard is one of the screening options the USPSTF actually recommends, not an off-label workaround 2.

how does cologuard work covers the mechanics of the test itself; this page is about what it costs and who is required to pay for it.

Who Qualifies for the No-Cost Screening Benefit

The no-cost benefit applies to average-risk adults in the recommended screening age range, currently starting at 45 2 — someone with symptoms, a strong family history, or a prior polyp is generally outside the population this specific coverage rule was built for, and usually needs a different test on a different timeline. Being outside average risk doesn't mean no coverage; it means a different coverage pathway, typically diagnostic rather than preventive.

Confirming you fall within the screening population, rather than assuming, is worth a phone call before ordering a kit — it's the detail most likely to determine whether the test is free or billed.

positive cologuard: What Happens to the Bill

what happens if cologuard is positive matters for your wallet as much as your health. Federal guidance treats a follow-up colonoscopy after a positive stool test as part of the screening process, covered the same way the original test was, rather than as a new diagnostic problem 1.

Not every plan applies that rule identically, and how a specific insurer or employer plan interprets it can vary. positive stool-DNA follow-up colonoscopy is the exact appointment this concerns, and it's worth confirming coverage details before testing, and again if a result comes back positive, rather than assuming the rule applies automatically to your bill.

What a Cologuard Kit Costs Without Insurance

There's no single list price to quote here honestly, because what a Cologuard kit actually costs varies by lab contract and by plan — but a real number exists, and it's findable. CMS publishes a Procedure Price Lookup tool showing national-average Medicare payment amounts for outpatient procedures, a useful starting point for understanding what a test like this is generally priced around, even though it isn't a Cologuard-specific figure 3.

cash-pay colonoscopy price walks through the same kind of question for the procedure Cologuard is meant to help some people avoid — reading both before deciding gives a fuller cost picture than either alone. Most insurers also publish their own cost-estimator tools now, and calling the number on the back of your insurance card and asking directly what a Cologuard kit would cost under your specific plan tends to produce a more reliable answer than any general price guide, including this one.

What to Ask Before You Order a Kit

A short call before ordering settles most of what matters: whether your plan classifies you as average-risk and screening-eligible, whether the lab that processes Cologuard kits is in-network, and what happens to the bill specifically if the result comes back positive. None of these are unusual questions for an insurer's member services line.

Keeping a record of that call — the date, who you spoke with, and what they told you — is worth doing precisely because coverage rules can be applied inconsistently in practice. If a bill later contradicts what you were told, that record is what supports an appeal.

Medicare and the No-Cost Rule

Original Medicare is split into Part A, hospital insurance, and Part B, medical insurance, which together are what most people mean by "Medicare" coverage for an outpatient test like Cologuard 4. Medicare Advantage plans, the private bundled alternative to Original Medicare, are required to cover at least the same benefits, including preventive screening 4.

That means the ACA's no-cost-sharing rule for Cologuard generally holds whether someone is on Original Medicare or a Medicare Advantage plan — the mechanics of the plan differ, but the screening benefit itself doesn't disappear. Someone unsure which type of Medicare coverage they have can find that answer on their Medicare card or their most recent plan documents, and it's worth knowing before the billing conversation, not during it.

Cost Isn't the Only Comparison: Accuracy

A free test isn't automatically the right test, and cost questions tend to come bundled with accuracy questions. The current version of Cologuard was validated in a large national trial reporting its sensitivity for colorectal cancer and its specificity in an average-risk population 5, while FIT, the blood-only stool test, has a pooled sensitivity of about 0.79 and specificity of about 0.94 across independent studies 6.

fit vs cologuard and how accurate is cologuard go into that trade-off in more depth than a cost page needs to — the short version is that the two stool-based tests are not interchangeable, and price alone shouldn't decide which one you use.

If Cologuard Isn't the Right Fit

Someone with symptoms, a strong family history, or a prior positive result generally isn't a candidate for Cologuard as their next test, regardless of what it costs — that population usually needs colonoscopy directly. cologuard vs colonoscopy walks through that comparison for people trying to decide between the two as a starting point rather than as a sequence.

virtual colonoscopy cost covers a third option, CT colonography, for anyone who wants to compare more than two paths before choosing. None of these decisions should be made on price alone, but knowing the real cost of each is part of making an informed one. And for anyone who simply cannot afford any of these options even after confirming coverage, the honest next step is a direct conversation with the ordering clinic about payment plans or a sliding-fee arrangement, rather than skipping screening altogether.

Common questions

For most average-risk adults 45 and older, yes — the ACA requires no-cost coverage for USPSTF-recommended colorectal cancer screening, and Cologuard is one of the tests that qualifies. Confirming you fall within that screening population, rather than assuming, is worth a call to your insurer before ordering a kit.

It's supposed to be — federal guidance treats that follow-up colonoscopy as part of the screening process rather than a new diagnostic problem. In practice, not every plan applies the rule identically, so confirming with your insurer before testing, and again if a result comes back positive, is worth doing rather than assuming it will be automatic.

There's no single honest number to quote, since it varies by lab contract and by plan. CMS's Procedure Price Lookup tool shows national-average Medicare payment amounts for outpatient procedures and is a reasonable starting point for understanding general pricing, though it isn't a Cologuard-specific figure — calling the lab and your insurer directly gets you the real number for your situation.

Generally yes. The same ACA no-cost-sharing rule for USPSTF-recommended screening applies to Original Medicare and to Medicare Advantage plans, which are required to cover at least the same benefits as Original Medicare. The mechanics of the plan differ, but the screening benefit itself doesn't disappear.

They're not measuring the same thing the same way, and guideline bodies generally treat colonoscopy as the more complete option. Cologuard combines a DNA and blood signal validated in a large national trial, while colonoscopy can see and remove a polyp in the same visit — cost and accuracy are two separate questions worth weighing together, not one deciding the other.

Someone with symptoms such as rectal bleeding, a strong family history of colorectal cancer, or a prior polyp generally isn't the population this screening test was built for, regardless of cost — that person usually needs colonoscopy directly, on its own timeline, rather than a stool-based screening test.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When cost shouldn't be the deciding factor

  • —Rectal bleeding, blood in the stool, or a new change in bowel habits — these need direct evaluation, not a routine screening test
  • —A first-degree relative with colorectal cancer or an advanced polyp, especially diagnosed before age 50
  • —Unintentional weight loss, persistent abdominal pain, or a known iron-deficiency anemia alongside a plan to order a stool test

This page explains how Cologuard is generally covered and priced. It is educational, not a guarantee of coverage for any individual plan, and it does not replace a direct conversation with your insurer or clinician about your own situation.

References

  1. 1.American Cancer Society (2024). Insurance Coverage for Colorectal Cancer Screening. American Cancer Society (cancer.org). link ✓That the ACA requires private insurers and Medicare to cover USPSTF-recommended colorectal cancer screening with no patient cost-sharing, and that a follow-up colonoscopy after a positive stool test is covered as screening — used for both the core coverage claim and the positive-result billing nuance.
  2. 2.U.S. Preventive Services Task Force (USPSTF) (2021). Colorectal Cancer: Screening (Final Recommendation). U.S. Preventive Services Task Force. link ✓That average-risk colorectal cancer screening is recommended starting at age 45 — used to define who qualifies for the no-cost screening benefit.
  3. 3.Centers for Medicare & Medicaid Services (2024). Procedure Price Lookup for Outpatient Services. Medicare.gov (CMS). link ✓That CMS publishes a Procedure Price Lookup tool showing national-average Medicare payment amounts for outpatient procedures — used to point readers toward a real cost-lookup method instead of an invented price figure.
  4. 4.Centers for Medicare & Medicaid Services (2024). Parts of Medicare. Medicare.gov (CMS). link ✓That Medicare is organized into Part A (hospital insurance) and Part B (medical insurance) as Original Medicare, with Part C (Medicare Advantage) as a private bundled alternative required to cover at least the same benefits — used to explain how Medicare's structure applies to Cologuard coverage.
  5. 5.Imperiale TF, Porter K, Zella J, et al. (BLUE-C Study Investigators) (2024). Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening. New England Journal of Medicine. doi:10.1056/NEJMoa2310336 ✓That the BLUE-C trial validated the current-generation multitarget stool DNA test, reporting its sensitivity for colorectal cancer and specificity in an average-risk population — used to note that a free test isn't automatically the most accurate test.
  6. 6.Lee JK, Liles EG, Bent S, Levin TR, Corley DA (2014). Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Annals of Internal Medicine. doi:10.7326/M13-1484 ✓That FIT has pooled sensitivity of about 0.79 and specificity of about 0.94 for colorectal cancer — used to contrast the cheaper, simpler alternative's accuracy against Cologuard.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library